Abstract
The specificity of drug targets is a great challenge in the pharma-proteomics field of cancer biology. In particular, bioinformatics methods based on complex networks and Gene Ontologies (GOs) are very useful in this area. This work reviews some bioinformatics concepts and previous studies related to Colorectal Cancer (CRC) research using GOs, complex networks, and related methods. Also, we report new results mapping natural compounds on potential drug target CRC network using GOs. The literature mining along with OMIM database gives the details of diseased genes which are further subjected to design a well connected gene regulatory network for cancer. The resultant network is then extrapolated to proteomics level to sort out the genes only expressed in the specific cancer types. The network is statistically analyzed and represented by the graphical interpretation to encounter the hub nodes and their locally parsed neighbors, ligands multi-receptor docking, and the propensity of drug targets in hub nodes and related sub-networks.
Keywords: Chemo preventive drugs, systems biology, mapping, colon cancer, gene ontology, Open Biomedical Ontologies, Colorectal Cancer, Kyoto Encyclopedia of Genes and Genomes, Unified Medical Language System, National Center for Biomedical Ontology
Current Bioinformatics
Title: Complex Network and Gene Ontology in Pharmacology Approaches:Mapping Natural Compounds on Potential Drug Target Colon Cancer Network
Volume: 6 Issue: 1
Author(s): Biplab Bhattacharjee, R. M. Jayadeepa, Usha Talambedu, Sanghita Banerjee, Jayadev Joshi, Jilu Princy Mole, Joshua Samuel and Sushil Kumar Middha
Affiliation:
Keywords: Chemo preventive drugs, systems biology, mapping, colon cancer, gene ontology, Open Biomedical Ontologies, Colorectal Cancer, Kyoto Encyclopedia of Genes and Genomes, Unified Medical Language System, National Center for Biomedical Ontology
Abstract: The specificity of drug targets is a great challenge in the pharma-proteomics field of cancer biology. In particular, bioinformatics methods based on complex networks and Gene Ontologies (GOs) are very useful in this area. This work reviews some bioinformatics concepts and previous studies related to Colorectal Cancer (CRC) research using GOs, complex networks, and related methods. Also, we report new results mapping natural compounds on potential drug target CRC network using GOs. The literature mining along with OMIM database gives the details of diseased genes which are further subjected to design a well connected gene regulatory network for cancer. The resultant network is then extrapolated to proteomics level to sort out the genes only expressed in the specific cancer types. The network is statistically analyzed and represented by the graphical interpretation to encounter the hub nodes and their locally parsed neighbors, ligands multi-receptor docking, and the propensity of drug targets in hub nodes and related sub-networks.
Export Options
About this article
Cite this article as:
Bhattacharjee Biplab, M. Jayadeepa R., Talambedu Usha, Banerjee Sanghita, Joshi Jayadev, Princy Mole Jilu, Samuel Joshua and Kumar Middha Sushil, Complex Network and Gene Ontology in Pharmacology Approaches:Mapping Natural Compounds on Potential Drug Target Colon Cancer Network, Current Bioinformatics 2011; 6 (1) . https://dx.doi.org/10.2174/157489311795222400
DOI https://dx.doi.org/10.2174/157489311795222400 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Application of Resveratrol in Diabetes: Rationale, Strategies and Challenges
Current Molecular Medicine Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy
Current Cancer Therapy Reviews Nanoparticles: Functionalization and Multifunctional Applications in Biomedical Sciences
Current Medicinal Chemistry Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology The Impact of Gynecological Cancer on Reproductive Issues and Pregnancy:Psychological Implications
Current Women`s Health Reviews Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Clinical Use of Therapies Targeting Tumor Vasculature and Stroma
Current Cancer Drug Targets Current Pharmacological Approaches to Prevent and Treat Post- Menopausal Osteoporosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) High Expression of miR-483-5p Predicts Chemotherapy Resistance in Epithelial Ovarian Cancer
MicroRNA Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors-Considerations for Successful Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk
Current Cancer Therapy Reviews Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective
Current Pharmaceutical Biotechnology Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Current Alzheimer Research The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target
Current Medicinal Chemistry Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor
Anti-Cancer Agents in Medicinal Chemistry TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
Current Medicinal Chemistry Unveiling Cancer in IBD: Screening Colonoscopy or Chromoendoscopy
Current Drug Targets Pharmacogenetics of Oxazaphosphorines and its Clinical Implications
Current Pharmacogenomics Application of Proteomics to the Discovery of Cancer Biomarkers
Current Cancer Therapy Reviews